IN VITRO TESTS PROVIDE INDISPENSABLE INFORMATION TO MEDICAL PROFESSIONALS TO DIAGNOSE AND TREAT DISEASE.

IN VITRO TESTS PROVIDE INDISPENSABLE INFORMATION TO MEDICAL PROFESSIONALS TO DIAGNOSE AND TREAT DISEASE. SUCH TESTS ARE USUALLY PERFORMED IN A LABORATORY REMOTE FROM THE PATIENT AND TAKE HOURS OR DAYS BEFORE RESULTS ARE AVAILABLE.BIOTRACK HAS DEVELOPED A NOVEL PROTHROMBIN TIME MONITOR DESIGN FOR PATIENT-SIDE USE. THE TEST USES A DROP OF FINGERSTICK BLOOD, IS SIMPLE AND RAPID TO PERFORM, AND IS AS ACCURATE AND PRECISE AS LABORATORY METHODS. THE PURPOSE OF THIS PROJECT IS TO EXTEND BIOTRACK'S SYSTEM TO OTHER TESTS IMPORTANT IN MANAGING CARDIOVASCULAR CONDITIONS. THESE INCLUDE DRUG TESTS FOR MONITORING AND ADJUSTING CARDIO-ACTIVE PHARMACEUTICAL THERAPY AND ENZYME TESTS AS MARKERS OF CARDIOVASCULAR DAMAGE. SPECIFICALLY THE COMPANY INTENDS TO DEVELOP A PORTABLE IMM UNOASSAY SYSTEM USING LASER OPTICS AND REAGENT ADDITION BY CAPILLARY FLOW IN WHOLE BLOOD SAMPLES PROVIDING IMMEDIATE RESULTS. BIOTRACK PROPOSES IN PHASE I TO SELECT A MODEL ANALYTE, (LIDOCAINE-USED AS AN ANTIARTHYTHMIC) AND ASSEMBLE THE COMPONENTS TO DEMOSTRATE FEASIBILITY OF AN IN-VITRO IMMUNOCHEMICAL BIOSENSOR. IN PHASE II, BIOTRACK WOULD DESIGN AND FABRICATE A PRE-PROTOTYPE SYSTEM THAT WOULD PERFORM IN A CLINICAL SETTING. REFINEMENTS OF THE PROTOTYPE WOULD LEAD TO THE FIRST OF SEVERAL COMMERCIAL PRODUCTS FOR PATIENT-SIDE IN-VITRO TESTING OF ANALYTES.